Download Anterior Iliac Crest Bone Graft (AICBG)

C a th e t e r
P l a c e m e n t
Anterior Iliac Crest
Bone Graft (AICBG)
T e ch n i q u e
Daniel Taub, MD, DDS - Robert Diecidue, MD, DMD, MSPH
Oral and Maxillofacial Surgery
Thomas Jefferson University Hospital
Philadelphia, PA
This material is provided for educational purposes and represents the technique used by the above surgeon. Catheter placement is
provided for guidance only and is subject to the individual expertise, experience and school-of-thought of the surgeon placing the
catheter. This protocol is not to be construed as I-Flow’s specific recommendation.
Sample Protocol
Drug Manufacturers’ Recommended Dose
Drug
Pump Used: PM022: 100 ml x 2 ml/hr
(1) 5” ON-Q Soaker® Catheter
Maximum
Maximum 24 Hour Dose
Drugs in Pump: 100 ml of 0.5% bupivacaine
Catheter Placement: 3 inches superior and lateral to incision
tunnel the catheter through the skin, subcutaneous fat and the
fascia. The ON-Q Soaker Catheter is placed along the bone
harvest site. The periosteum is reapproximated and the wound is
closed in layers.
Catheter Securement Technique: Catheter is secured with Steri-Strips™.
The flow restrictor is placed on the skin and secured with a clear
occlusive dressing.
Results with ON-Q: Percocet® or the physician’s pain medication of
choice should be available for breakthrough post operative pain.
Before ON-Q
After ON-Q
Pain Management Method:
NSAIDs/narcotics
opioids for
breakthrough
pain only
Average Narcotic Usage:
one week
3 days
Average Length of Stay:
3-4 days
2 days
Bupivacaine
(Marcaine®, Sensorcaine®)
400 mg
Levobupivacaine
(Chirocaine®)
695 mg
Ropivacaine
(Naropin®)
770 mg
Maximum Total Dose
(24 hour dose not specified)
Lidocaine
(Xylocaine)
300 mg
All local anesthetics are without epinephrine and
manufacturer recommendations should be regarded
as guidelines for use in adults.
Other Notes: Subjective data per patient report: within 24 hours after AICBG pain score is 0/10. 24 hours after removal of catheter
pain levels have increased to 4-5/10 with overall opioid requirement decreased.
CAUTIONS
• Medications used with this system should be administered in accordance with instructions provided by the drug manufacturer (see guidelines above).
Surgeon is responsible for prescribing drug based on each patient’s clinical status (e.g., age, body weight, disease state of patient).
• Vascoconstrictors such as Epinephrine or Adrenaline are not necessary and may not be recommended for continuous infusions.
• Refer to ON-Q PainBuster Directions for Use for full instructions on using the ON-Q PainBuster System.
1305180A Page 1 of 2
AICBG
These illustrations are for general guidance only and not intended to be interpreted as precise anatomical illustrations.
iNTRAORAL DEFECT
BONE HARVESTED WITH CATHETER PLACEMENT
CATHETER PLACEMENT
SECUREMENT
20202 Windrow Drive
Lake Forest, CA 92630
Phone: 800-448-3569/949-206-2700
www.iflo.com
" ‡+Ê-Ê /Ê",\
UÊÊ-ˆ}˜ˆvˆV>˜ÌÞÊLiÌÌiÀÊ
ÊÊ «>ˆ˜ÊÀiˆivÊ̅>˜Ê˜>ÀVœÌˆVÃ
UÊÊ-ˆ}˜ˆvˆV>˜ÌÞʏiÃÃʘii`Ê
Ê ÊvœÀʘ>ÀVœÌˆVÃ
Rx only
I-Flow, ON-Q, PainBuster and Soaker are
registered trademarks of I-Flow Corporation.
Redefining Recovery is a trademark of I-Flow
Corporation.
© 2007 I-Flow Corporation. All rights reserved.
1305180A Page 2 of 2